| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC2881 |
| Trial ID | NCT05170568 |
| Disease | Non-Hodgkin's Lymphoma |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PA3-17 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies |
| Year | 2021 |
| Country | China |
| Company sponsor | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
| Other ID(s) | PG-CART-07-001 (1) |
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||